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Diabetic nephropathy (DN) is a major cause of end-stage renal disease and its mortality is
continuously increasingworldwide. Previous studies indicate that reactive oxygen species play
an important role in high glucose-induced renal injury.Myrciaria cauliflorahas been reported as
a functional food rich in anthocyanins possessing anti-oxidative and anti-inflammatory
properties. This study examined whether M. cauliflora extracts (MCE) can attenuate diabetic
nephropathy progression in type 2 diabetes mellitus mice. First, the composition of the an-
thocyanins and polyphenols of MCE were determined by high-performance liquid chroma-
tography and spectrophotometry. One hundred mg/kg of streptozotocin and 240 mg/kg
nicotinamidewere administered to C57BL/6Jmice fed a high fat diet and varied concentrations
of MCE. The plasma glucose concentration, body weight, oral glucose tolerance, blood pres-
sure, renal ultrasound ultrasonic wave were monitored every 2 weeks. Following euthanasia,
the kidneys of the mice were analyzed using hematoxylineeosin, periodic acid Schiff, Mas-
son's trichrome, and immunohistochemistry staining. The results showed that MCE stabilized
the plasma glucose and indirectly improved insulin sensitivity in diabetic mice. In addition,
diabetes-caused glomerular atrophy, accumulation of saccharide, and formation of collagen IV
were recovered or reduced under treatment with MCE in diabetic mice. Our results indicate
that MCE has beneficial effects in DN and the mechanism has been confirmed to inhibit Ras/
PI3K/Akt and kidney fibrosis related proteins. This work illustrates the potential of MCE rich in
anthocyanins and polyphenols as a natural food to inhibit DN.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).edicine, Chung Shan Medical University, Taichung, Taiwan.
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Diabetic nephropathy (DN) is a pathological progression from
hyperfiltration to microalbuminurea, then to macro-
albuminurea, and finally to renal failure [1]. A typical
morphological change in the diabetic kidney involves the
accumulation of extracellular matrix (ECM) in glomeruli that
correlates with the loss of renal function such as mesangial
expansion, tubulointerstital fibrosis, and irreversible deterio-
ration [2,3]. Under diabetic conditions, the synthesis of matrix
proteins including collagen IV and fibronectin are upregulated
in mesangial cells, ultimately leading to glomerulosclerosis
[3,4]. The boosted production of matrix proteins can be
responsible for hyperglycemia-associated accumulation of
ECM constituents at the glomerular levels [5,6].
In addition to high glucose, Ras/Rho are stimulated by
other components of the diabetic milieu, such as advanced
glycation end products (AGEs), reactive oxygen species, the
hexosamine pathway and oxidized low-density lipoprotein
in renal cells [7e10]. Ras family members are downstream
convergence points for signal cascades mediated by many
cell surface receptors with ligands expressed in renal
injury, such as transforming growth factor b (TGF-b),
platelet-derived growth factor (PDGF), angiotensin II, and
epidermal growth factor (EGF), allowing transduction of the
signal to downstream profibrotic effectors. As such, they
may be an important potential target for treating the
fibrosis of chronic kidney disease [11e14]. As demonstrated
by initial studies, the pathway contributes to progrowth,
profibrotic/prosclerotic signalling, and enhanced ECM pro-
duction [7,8]. The effects of high glucose on mesangial cells
were inhibited by simvastatin [15], Y27632 (ROCK inhibitor),
or fasudil, as well as the transfection of mesangial cells
with inactive RhoA mutant or siRNA targeting RhoA.
However, nephropathy induced by diabetes involved in Ras
signaling is still unclear.
Polyphenols are a large family of antioxidant phytochem-
icals in our diet. According to the recent literature, the
mechanism by which polyphenols express their beneficial
properties on DN appears to be through inhibition of
glomerular hypertrophy [16]. Studies show that some of those
exhibit high biologic potential, since they have higher fiber
and antioxidant contents, such as in several phenolic com-
pounds and anthocyanins [17, 18]. Jaboticaba (Myrciaria cauli-
flora), a native fruit from the Brazilian Atlantic Forest, has a
peel with interesting nutritional properties. It is a good source
of minerals, fibers, and phenolics, especially anthocyanins
[19e21]. Jaboticaba is cited in popular medicine as an astrin-
gent, useful against diarrhea, skin irritations, gut inflamma-
tion, and hemoptysis [22]. Besides, Leite-Legatti et al showed
that freeze-dried jaboticaba peel powder increased high-
density lipoprotein cholesterol and improved insulin resis-
tance in rats in a diet-induced obesity model [21]. Dragano
et al also showed improvements in insulin sensitivity in
highefat-fed mice after intake of the same freeze-dried jabo-
ticaba peel powder [23]. However, these recent studies did not
evaluate the preventive effects of jaboticaba peel intake
regarding the risk factors for DN. The aim of this study was to
determine the effects of M. cauliflora water extract (MCE)intake in streptozotocin (STZ)/nicotinamide (NA) mice fed a
high-fat diet.2. Materials and methods
2.1. Preparation and analysis of the compositions of
MCE
MCE were prepared from the fruit of M. cauliflora Berg, which
were obtained from the Modern Garden Jabuticaba Co., Ltd,
Changhua, Taiwan. Briefly, the lyophilized fruit (100 g) were
macerated and stirred with water (100 mL), and the juice was
then filtered and centrifuged (10,000  g, 15 minutes). The
extract was filtered and concentrated under reduced pressure
at 30C. Then, the filtrate was lyophilized (80C, 12 hours) to
obtain MCE and stored at 20C before use. The concentration
of total polyphenol was analyzed according to a
FolineCiocalteu assay. The MCE (0.1 mg) were dissolved in an
eppendorf with 1 mL of distilled water, and FolineCiocalteu
reagent (2N, 0.5 mL) was then added andmixed for 3 minutes.
The mixture had 3 mL of 2% Na2CO3 added and it then stood
for 15 minutes with intermittent mixing. The absorbance of
the mixture was measured at 750 nm using a Hitachi U-3210
spectrophotometer (Hitachi, Tokyo, Japan) with gallic acid as
the standard.
2.2. High-performance liquid chromatography and
polyphenols content analysis of MCE
The polyphenols were identified by high-performance liquid
chromatography (HPLC) analysis using a Hewlett-Packard
Vectra 436/33N system with a diode array detector. The
25 mg/mL of MCE were filtered through a 0.22-mm filter disk
and injected into the column employing a 5-mmRP-18 column
(4.6 mm  150 mm inner diameter). The eluted polyphenols
were monitored at 280 nm, and UV spectra were collected to
confirm peak purity. Two solvent systems were used in the
mobile phase: A, 2% acetic acid/water; B, 0.5% acetic acid in
water/acetonitrile.
2.3. Animal model
Male C57BL/6J mice, age 5e6 weeks, were used in the in vivo
studies; all mice were handled according to the guidelines of
IACUC (Institutional Animal Care and Use Committee), CSMU
(Animal Center of Chung Shan Medical University) and kept
on a 12 hour light/dark cycle in a temperature-controlled
vivarium. They were allowed to take food and water ad libi-
tum before any food-related treatment began. Mice were
fasted for 16 hours before receiving the chemicals. STZ was
dissolved in a 50mM citric acid buffer at the time of use and
was administered at 100 mg/kg, intraperitoneally twice on
Days 0 and 2. NA was dissolved in saline and injected at
240 mg/kg intraperitoneally at 15 minutes before adminis-
tration of STZ. The blood sugar (BS) level and body weight
were measured every 2 weeks. Biochemical measurements
and pathological examinations were performed 8 weeks
later.
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Mice were fasted for 16 hours before oral administration of
glucose solution (2.0 g/kg), and the BS level was measured at
0 minutes, 15 minutes, 45 minutes, 95 minutes, and 135 mi-
nutes following glucose administration atWeeks 0, 2, 4, 6, and
8 after induction of diabetes.
2.5. Measurement of biochemical parameters in blood
and urine
Blood was collected from the tail vein of the mice every
2 weeks after beginning the induction of diabetes. BS con-
centration was measured 16 hours after removal of food at 7
PM as a ‘fasting’ BS level, using a blood glucose meter (Accu-
Chek Performa; Roche, Nutley, NJ, USA). Immediately after
measuring the BS concentration, food was given to mice. For
urine collection, mice were transferred to clean metabolic
cages (one mouse per cage). Total protein, creatinine and al-
bumin in the urine were determined by a Mouse Albumin
ELISA Kit (Bethyl Laboratories Inc., Montgomery, TX, USA) and
QuantiChromCreatinine Assay Kit (BioAssay Systems, Hay-
ward, CA, USA) according to the manufacturer's procedures.
Mouse urinary albumin/urinary creatinine ratio was calcu-
lated as mg/mg [24].
2.6. Renal morphology assessment and
immunohistochemistry analysis
Hematoxylineeosin, periodic acideSchiff (PAS), and Masson's
trichrome stainings were performed by conventional histo-
chemical methods described previously [25]. After the mice
were euthanized, full-thickness biopsies were taken and fixed
in 4% formaldehyde, and then embedded in paraffin. Tissue
slices were subjected to hematoxylineeosin staining. For PAS
staining, the kidneys were harvested and fixed in 10%
formalin; 5-mm thick sections were stained with PAS reagent.
Immunohistochemistry was performed in paraffin sections
and detected in cortical sections with a specific primary
antibody and the ABC staining kit, and visualized with the
DAB detection kit (both kits from Vector Laboratories Inc.,
Burlingame, CA, USA). The primary antibody used in the
present study was RAS (Sigma; Maixin, Fuzhou, China). After
being incubated with the secondary antibody (Proteintech
Group, Chicago, IL, USA), 2-mm thick sections were developed
with an SP immunohistochemical kit (Maixin, China) to pro-
duce a brown product and counterstained with hematoxylin.
Histologic evaluation was performed using a Nikon Eclipse
E600 microscopy system (Nikon Instruments Inc., Melville,
NY, USA) without knowledge of the identity of the various
groups. The slides were coded and examined by a pathologist
blinded to the study protocol to identify histological
alterations.
2.7. Measurement of cell proliferation
A murine kidney mesangial cell line (MES13) was obtained
from BCRC (Bioresource Collection and Research Center,
Hsinchu, Taiwan) and grown in a 3:1 mixture of Dulbecco'smodified Eagle medium and Ham's F-12 medium containing
5% (v/v) fetal bovine serum, 4mM L-glutamine, 1mM peni-
cillin/streptomycin, and 5.5mM glucose. All cell cultures
were maintained at 37C in a humidified atmosphere of 5%
CO2e95% air. The cell proliferation assay was performed
using the MTT [3-(4, 5-dimethylthiazol-2-vl)-2, 5-diphenyl
tetrazolium bromide] assay. MES13 cells were seeded and
treated with MCE of 0.2 mg/mL, 0.4 mg/mL, and 0.6 mg/mL
for 1 day, 2 days, or 3 days in 25mM high glucose medium
conditions. The mediums from all treatments were
removed, and the cells were washed with phosphate-
buffered saline. After adding fresh medium, the cells
were incubated with 20 mL MTT (5 mg/mL) for 4 hours.
Then, the blue crystals, which are the metabolized prod-
ucts of MTT, were extracted by isopropanol. Absorbance at
563 nm was measured and used for the proportion of
proliferating cells.
2.8. Western blot analysis
Immunoblot analysis was performed according to standard
protocols. After resolution on sodium dodecyl sulfa-
teepolyacrylamide gel electrophoresis gels, proteins were
electroblotted onto an immobiolon-NC (nitrocellulose)
membrane that was subsequently blocked with 1% (w/v)
nonfat milk in Tris-buffered saline containing 0.1% (v/v)
Tween-20 (TBST). The membranes were washed with TBST
and incubated with the indicated primary antibody in
TBST. After extensive washing with TBST, the blot was
then incubated with the appropriate horseradish
peroxidase-conjugated secondary antibody. Band detection
was revealed by enhanced chemiluminescence (ECL) using
ECL western blotting detection reagents and exposure to
ECL hyperfilm on a FUJIFILM Las-3000 system (FUJFILM Co.,
Tokyo, Japan). The proteins were then quantitatively
determined by densitometry using FUJFILM-Multi Gauge
V2.2 software.
2.9. Statistical analysis
Statistical analysis was performed with Sigmaplot software
(version 12), and descriptive statistics are presented as
mean ± standard deviation. The difference among the three
groups (control, STZ/NA-induced, and MCE groups) was
analyzed by one-way ANOVA. The difference between two
groups was analyzed by Student t test.3. Results
3.1. Polyphenol content in MCE
After water extraction, the yield of MCE was approximately
2.5% and the phytochemical profile was analyzed by HPLC
and spectrophotometry (Figure 1). According to the cali-
bration standards, the major polyphenol of MCE was pro-
tocatechuic acid (73.82%), and the other polyphenolic
constituents of MCE were gallic acid (9.57%), gallocatechin
(9.32%), catechin (4.00%), and rutin (3.28%) as analyzed by
Fig. 1 e High-performance liquid chromatogram of Myrciaria cauliflora extract (MCE). (A) Polyphenol contents of nine
polyphenols standards (1mg/mL;10mL) are: 1. gallic acid, 2. protocatechuic acid, 3. catechin, 4. gallocatechin, 5. gallocatechin
gallate, 6. caffeic acid, 7. rutin, 8. quercetin, 9. naringenin. (B) Polyphenol contents of MCE (10 mg/mL; 10mL). (C) Anthocyanin
contents of MCE. Retention time for: delphinidin, 16.54 minutes; cyanidin, 25.75 minutes; peonidin, 27.56 minutes.
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ence of several unidentified peaks. The main anthocyanins
of MCE were delphinidin (58.08%), cyanidin (14.94%), peo-
nidin (10.70%), and unknown components with our stan-
dards (Table 2).3.2. MCE mitigated BS and renal injury in diabetic mice
The BS of the mice was monitored by OGTT every 2 weeks.
MCE could stabilize the fasting BS of diabetic mice induced by
STZ/NA for the whole experiment (Figure 2A). In addition,
Table 1 e Identification of polyphenol content in
Myrciaria cauliflora extract.
Polyphenol % mg/100 g of FW
Dry Fresh
Gallic acid 9.57% 96 2.4
Protocatechuic acid 73.82% 738 18.45
Catechin 4.00% 400.1 10.0025
Gallocatechin 9.32% 93 2.325
Rutin 3.28% 33 0.825
FW ¼ weight of M. cauliflora fruit.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 1 3 6e1 4 6140high BS was detected in STZ/NA mice at 2 weeks and 1% MCE
significantly ameliorated the high BS level after treatment for
6 weeks (Figure 2B), indicating the effect of MCE in regulating
BS. The STZ/NA mice caused slight weight gain, significant
hyperlipidemia, and high blood urea nitrogen (BUN), creati-
nine, and blood pressure, as shown in Table 3. MCE improved
STZ/NA-induced hyperlipidemia-induced by decreasing tri-
acylglycerol and total cholesterol levels. MCE also had an
inhibitory effect on the BUN, blood creatinine, and blood
pressure. However, there was no difference between the STZ/
NA-induced and MCE treatment groups as to the urine creat-
inine level (data not shown). Then the urine albumin level was
determined. The ratio of urine albumin/urine creatinine, an
indicator of renal dysfunction, increased in the STZ/NA group
and could be alleviated by MCE treatment.Fig. 2 e Fasting blood sugar level in the mice from Week
0 to Week 8. After treatment with streptozotocin/
nicotinamide (STZ/NA), mice were fed with high fat diet
and three concentrations of Myrciaria cauliflora extract
(MCE), this fasting blood glucose of mice were tested every
2 weeks. Data are shown as mean ± standard deviation;
n ¼ 10 mice per group. yp < 0.05 versus control group;
*p < 0.05, **p < 0.001 versus STZ/NA group.3.3. MCE decreased the ECM accumulation of glomeruli
in STZ/NA mice
ECM accumulation is one of the characteristic pathological
alterations in the glomeruli of diabetic nephropathy patients.
Both collagen and fibronectin are the predominant compo-
nents of ECM and generally considered the predictors of ECM
accumulation. Representative glomerular atrophy and
mesangial matrix expansion were observed in the STZ/NA
group compared with the control group, andMCE ameliorated
glomerular atrophy and mesangial matrix expansion induced
by STZ/NA (Figure 3A). Figure 3B shows the quantification of
mesangial matrix expansion. The mesangial matrix index,
calculated by thewhite circle area in the tuft area, increased in
the STZ/NA group and was significantly reduced by MCE
exposure.
STZ/NA also induced significant kidney damage, as
revealed by PAS staining. PAS staining is most useful for
analyzing the glomerulus, since it delineates the glomerular
cells, mesangial matrix and potential expansion in great
detail, as well as potential modifications of the composition of
the matrix, changes in the glomerular basal membrane, i.e.Table 2 e Identification of anthocyanins from jaboticaba.
Anthocyanin % mg /100 g of weight
Dry Fresh
Delphinidin 58.08% 581 14.5
Cyanidin 14.94% 149 3.725
Peonidin 10.70% 107 2.675thickening, irregularities, doubling, rupture, and finally fibri-
noid necrosis of the glomerular tuft. Histological examination
and quantification revealed prominent nodular glomerulo-
sclerosis with glomerular basement membrane thickening
indicated by the arrow. This injury was attenuated dose-
dependently by MCE treatment in mice, proving MCE has the
potential to ameliorate diabetic nephropathy (Figure 4).
Changes in mesangial and tubulointersticial fibrosis indi-
cated by Masson's trichrome staining are shown in Figure 5.
Increased collagen deposition observed in the STZ/NA group
compared with control group was inhibited by MCE in a dose
dependent manner.
3.4. MCE decreased Ras-related protein expression in
STZ/NA mice
The Ras pathway is activated in renal cells exposed to diabetic
milleu, indicating a candidate role of Ras in DN [9,15]. Using
Table 3 e Biochemical characteristics after 8 weeks of treatment with Myrciaria cauliflora extract (MCE) in streptozotocin/
nicotinamide (STZ/NA) mice.
Control STZ/NA STZ/NA þ 0.1% MCE STZ/NA þ 0.5% MCE STZ/NA þ 1.0% MCE
BW (g) 22.5 ± 1.50 24.3 ± 0.60 24.7 ± 0.80 25.5 ± 0.96 24.9 ± 1.00
BUN (mg/dL) 17.43 ± 0.77 29.21 ± 1.01y 26.37 ± 0.91* 25.81 ± 1.31* 24.11 ± 0.57*
Cre (mg/dL) 0.21 ± 0.03 0.33 ± 0.02y 0.25 ± 0.02* 0.2 ± 0.03* 0.18 ± 0.02**
HDL/LDL 7.05 ± 0.57 7.52 ± 0.70 4.32 ± 0.51* 8.43 ± 0.99 5.81 ± 0.69**
TG (mg/dL) 55.86 ± 8.10 71.71 ± 4.89y 63.67 ± 2.17* 65 ± 5.72* 64.88 ± 4.85*
TC (mg/dL) 82.22 ± 4.17 119.29 ± 6.13y 107.78 ± 4.15 97.83 ± 5.61* 79.22 ± 4.43*
BP (mmHg) 90 ± 5.03 101 ± 1.15y 91.83 ± 2.47* 94.8 ± 2.96* 76.5 ± 3.62*
UACR (mg/mg) 33.2 ± 2.5 100.3 ± 6.3y 89.1 ± 5.7* 65.6 ± 2.7* 44.9 ± 2.1**
Data are presented asmean ± SD; n¼ 10mice per group. yp < 0.05, significant difference compared to the control group determined by Student's t
test.*p < 0.05, and **p < 0.001, significant difference compared to the STZ/NA group determined by ANOVA.
BP ¼ blood pressure; BUN ¼ blood urine nitrogen; BW ¼ body weight; Cre ¼ creatinine; HDL ¼ high-density lipoprotein; LDL ¼ low-density li-
poprotein; TC ¼ total cholesterol; TG ¼ triacylglycerol; UACR ¼ urinary albumin/urinary creatinine.
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sion of Ras protein was observed in the STZ/NA treated group,
whichwas as expected. The activated Ras in themice samples
was decreased in the MCE treatment groups (Figure 6). As
previous research showed, Ras activation was associated with
Akt activation [26]. Further details of the mechanism are
analyzed as follows.
3.5. Effect of MCE on high glucose-induced mesangial
cell proliferation
The cytotoxicity effect of MCE on MES13 mesangial cells was
determined first. Cell viability of 100e85% with MCE at
0e1 mg/mL revealed no cytotoxicity to MES13 cells (data notFig. 3 e Myrciaria cauliflora extract (MCE) decreases mesangial m
embedded in paraffin, stained with hematoxylin and eosin. Lig
sections from control group (a), streptozotocin/nicotinamide (ST
NA þ 0.5% MCE group (d), and STZ/NA þ 1.0% MCE group (e). Ar
expansion in the glomerulus. (B) Quantification of the mesangial
were examined. Data are shown as mean ± standard deviation
*p < 0.05, **p < 0.001 versus STZ/NA group.shown). MCE concentrations of 0.2 mg/mL, 0.4 mg/mL, and
0.6 mg/mL were selected for the following experiment. In the
MTT assay, stimulation with high glucose (25mM) increased
MES13 cell proliferation compared with the control (5.5mM
glucose) group. MCE (0.2 mg/mL, 0.4 mg/mL, and 0.6 mg/mL)
inhibited high glucose-induced cell proliferation dose depen-
dently (Figure 7).
3.6. Interruption of high glucose-induced mesangial
fibrosis signaling by MCE
The levels of collagen, fibronectin, and Ras related pathway
proteins assayed in the animal model were determined
in vitro. In Figure 8, whenMES13 cells were treated with 25mMatrix expansion in the glomerulus. (A) Kidney slices were
ht photomicrographs (400£ magnification) of kidney
Z/NA) group (b), STZ/NA þ 0.1% MCE group (c), STZ/
row indicates white circle, the location of mesangial matrix
matrix area. Three randomly selected glomeruli per mouse
; n ¼ 10 mice per group. yp < 0.05 versus control group;
Fig. 4 e Myrciaria cauliflora extract (MCE) decreases accumulation of saccharide in the glomerular periphery. Periodic
acideSchiff staining was used to detect accumulation of saccharide. (A) Light photomicrographs of kidney sections from the
control group (a), streptozotocin/nicotinamide (STZ/NA) group (b), STZ/NA þ 0.1% MCE group (c), STZ/NA þ 0.5% MCE group
(d), STZ/NA þ 1.0% MCE group (e) were displayed (400£ magnification). Arrow indicates mauve color, the location of
saccharide accumulated in the glomerulus. (B) The accumulation of saccharide index, calculated by the periodic acideSchiff-
positive area in the tuft area, was significantly increased in STZ/NA group as compared with the other four groups. Three
randomly selected glomeruli per mouse were examined. Data are shown as mean ± standard deviation; n ¼ 10 mice per
group. yp < 0.05 versus control group; *p < 0.05, **p < 0.001 versus STZ/NA group.
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increased, whereas MCE attenuated both proteins levels
under high glucose conditions. In addition, as expected, MCE
inhibited Ras and p-Akt levels induced by high glucose. A
previous study demonstrated that phosphoinositide 3-kinase
(PI3K) activation was a crucial event for the induction of
ECM protein in mesangial cells [13], and we also investigated
the influence of high glucose on PI3K activity. High ambient
glucose induced a significant increase in p-phosphoinositide
3-kinase (p-PI3K) activity and MCE dose dependently
decreased p-PI3K expression. Taken together, our findings
demonstrate that MCE ameliorates mesangial fibrosis, at least
in part, via the Ras/PI3K/Akt signaling pathway.4. Discussion
DN is one of the major complications of diabetes mellitus and
a leading cause of end-stage renal failure in the world today.
Ras is activated and regulates both cell proliferation and TGF-
b-induced epithelial-mesenchymal transition during renal
fibrosis. In this study, MCE ameliorating the structural and
functional abnormalities of the diabetic kidney in mice might
be associated with inhibition of Ras regulated renal fibrosis.
The STZ-induced diabetic animal model has been widely
used in DN research. STZ is a chemical inducer used for type
1 diabetes through producing free radicals in the body,specifically cutting DNA chains in the pancreatic beta cells,
and resulting in disorder in the function and destruction of the
b cells [27]. Nakamura et al established that the STZ/NA dia-
betic model possesses characteristics quite similar to type 2
nonobese diabetes, which constitutes a majority of East Asian
diabetic patients [28]. By supplement with NAD, the progress
of insulin-dependent diabetes could be prevented [29]. When
given the calorie-controlled high fat diet, the STZ/NA mice
caused hyperlipidemia, and significantly increased insulin
resistance. The diabetic mice model was used in the present
study and the STZ/NA group exhibited significant hyperlip-
idemia, as well as high BUN, creatinine, blood pressure, and
fasting blood sugar compared with the control group (Table 3,
Figure 2). In addition, renal dysfunction including ECM accu-
mulation, mesangial cell matrix deposition, and glomerular
basement membrane thickening were found in the kidney
sections of the STZ/NA group. Interestingly, MCE attenuated
the morphological alterations and improved renal function,
indicating MCE could reduce the risk of renal dysfunction by
preventing injury to the structure and cellular basis.
Glomerular mesangial cells and interstitial fibroblasts are
renal cells with an essential role in the development of renal
fibrosis [30,31]. Proliferation of renal fibroblasts has been
implicated in the pathophysiology of interstitial fibrosis, since
fibroblast activation leads to themyofibroblast phenotype and
a subsequent increase in extracellular matrix deposition.
Hyperglycemia and TGF-b are the pathogenic factors for
Fig. 5 e Myrciaria cauliflora extract (MCE) reduces collagen fiber expansion in the glomerular periphery. (A) Light
photomicrographs of kidney sections from control group (a), streptozotocin/nicotinamide (STZ/NA) group (b), STZ/NAþ 0.1%
MCE group (c), STZ/NA þ 0.5% MCE group (d), STZ/NA þ 1.0% MCE group (e) stained by Masson's trichrome reagent were
displayed (400£magnification). Arrow indicates blue color, the location of collagen fiber expansion in the glomerulus. (B)
The collagen fiber expansion, a kidney injury marker, was calculated by the Masson's trichrome-positive area in the tuft
area. Data are shown as mean ± standard deviation; n ¼ 10 mice per group. yp < 0.05 versus control group; *p < 0.05,
**p < 0.001 versus STZ/NA group.
Fig. 6 e Myrciaria cauliflora extract (MCE) decrease the Ras expression. (A) Light photomicrographs of kidney sections from
control group (a), streptozotocin/nicotinamide (STZ/NA) group (b), STZ/NA þ 0.1% MCE group (c), STZ/NA þ 0.5% MCE group
(d), STZ/NA þ 1.0% MCE group (e) were displayed Ras level using IHC staining (400£ magnification). Arrow indicates the
location of Ras expression. (B) The Ras protein expression significantly increased in STZ/NA group as compared with the
other group. Data are shown as mean ± standard deviation; n¼ 10 mice per group. yp < 0.05 versus control group; *p < 0.05,
**p < 0.001 versus STZ/NA group.
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Fig. 7 e The effect of Myrciaria cauliflora extract (MCE) on
MES-13 cells proliferation induced by high glucose. MES-
13 cells were induced by 25mM glucose medium and
treated with indicated concentration of MCE for 24 hours,
48 hours, and 72 hours. The 5.5mM glucose medium
cultured cells were as control group. Cell viability was
measured by 3-(4, 5-dimethylthiazol-2-vl)-2, 5-diphenyl
tetrazolium bromide assay. The data the
means ± standard deviation from three replicates per
treatment. *p < 0.05, **p < 0.001, significant difference
compared to the low glucose (control) group determined by
Student t test.
Fig. 8 eMyrciaria cauliflora extract (MCE) inhibited the proliferati
by high glucose. High glucose medium (25mM) was used to indu
the indicated concentration of MCE for (A) 48 hours and (B) 72 h
were as a control. Protein expression was detected by western b
representative of three independent experiments with compara
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 1 3 6e1 4 6144diabetic nephropathy. Besides, many of the cytokines, growth
factors, and integrins involved in proliferation are known to
activate intracellular signaling pathways that converge on Ras
proteins [32]. Our results showed high level expression of Ras
protein in both STZ/NA-induced group mice and MES13 cells
treated with high glucose, whereasMCE treatment attenuated
this increase, suggesting that MCE improved renal injury by
regulating the Ras pathway to reduce extracellular matrix
deposition such as collagen and fibronectin.
There is a close relationship between TGF-b and Ras
signaling: TGF-b overcomes the Rasmitogenic effects, and Ras
can counteract TGF-b signaling, altering the expression of the
TGF-b receptor. By contrast, renal Ras activation serves as an
intracellular signal transduction pathway for molecules
involved in obstructing kidney damage, such as TGF-b [33].
Interestingly, data from our other study revealed that MCE
could offer a prophylactic role against diabetic nephropathy
through inhibiting oxidative stress and inflammatory
response (unpublished data).
Thousands of studies have been conducted on better
treating and improving DN. Unfortunately, the pathogenesis
of DN remains unclear, and effective and safe therapies are in
great demand. Rather than conventional medicines that
concentrate on delaying renal failure by controlling BS, blood
pressure, and/or ameliorating microalbuminuria, BUN, and
creatinine, plant-based food rich in phytochemical or edible
traditional Chinese medicine emphasize the patients' overall
inner system and focus on repairing the kidney with consid-
eration of overall health. Recently, the anti-DN activity of
lignans from edible plants has been investigated. For example,
cinnamaldehyde from Cinnamomum zeylanicum has been
shown to exert protective effects against alloxan-inducedon and fibrosis proteins expression of MES-13 cells induced
ce the proliferation in MES-13 cell, which were treated with
ours, and cells treated with low glucose medium (5.5mM)
lot analysis and quantified by densitometry. The data were
ble observations.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 1 3 6e1 4 6 145renal damage by reducing glomerular expansion [34]. Flavo-
noids with anti-DN effects are commonly found in edible
plants such as green tea (Camellia sinensis), rooibos tea (Aspa-
lathus linearis), and lingonberry (Vaccinium vitisidaea) [35e37].
Recent research using STZ induced rats as a diabetic model
revealed renal function, blood glucose and glycated protein
profiles were improved in rats supplementedwith green tea in
the drinking water. There are reports glomerular hypertrophy
being inhibited through consumption of herbal antioxidants
extracts such as garlic, ginger [38], and Ginkgo biloba [39] in
diabetic animals. In addition, glomerular hypertrophy has
been inhibited by antioxidants such as vitamin E and a-
tochopherol in diabetic rats [40,41]. Anthocyanins are widely
distributed in human diets, suggesting that we ingest large
amounts of anthocyanins from plant-based foods. Anthocy-
anins are a class of flavonoids with high antioxidant ability,
responsible for the bright colors visible in most fruits and
vegetables. Many researchers have focused on the protective
effects of grape proanthocyanidins against DN. It was
discovered the proanthocyanidins could reduce serum AGEs,
proteinuria, and systolic blood pressure, decrease the receptor
of advanced glycation end-products and connective tissue
growth factor expression as well as oxidative stress in the
kidney, while increasing renal antioxidant enzyme activity
[42,43]. Purple corn has been classified as a functional food
rich in anthocyanins, dampening high-glucose-induced
mesangial fibrosis and inflammation [44]. M. cauliflora has
been reported to be rich in phenolic constituents, including
resorcinol, p-hydroxybenzoic acid, anthocyanins, hydrox-
ycinnamic acids, flavonoids, coumarins, and ellagitannins.
Phenolic compounds are well-known to be potent de-
activators of reactive species, having strong antioxidant and
anti-inflammatory biological properties [45], as well as anti-
cancer potency [46,47]. This is the first study showing the
potential of MCE as a natural food to inhibit DN.Conflicts of interest
The authors declare that they have no competing interests.Acknowledgments
This investigation was supported by the Chung Shan Medical
University and Chi Mei Medical Center (CSMU-CMMC-101-01).r e f e r e n c e s
[1] Roshan B, Stanton RC. A story of microalbuminuria and
diabetic nephropathy. J Nephropathol 2013;2:234e40.
[2] Kolset SO, Reinholt FP, Jenssen T. Diabetic nephropathy and
extracellular matrix. J Histochem Cytochem 2012;60:976e86.
[3] Mason RM, Wahab NA. Extracellular matrix metabolism in
diabetic nephropathy. J Am Soc Nephrol 2003;14:1358e73.
[4] Lin CL, Wang JY, Ko JY, Huang YT, Kuo YH, Wang FS.
Dickkopf-1 promotes hyperglycemia-induced accumulationof mesangial matrix and renal dysfunction. J Am Soc Nephrol
2010;21:124e5.
[5] Pozzi A, Voziyan PA, Hudson BG, Zent R. Regulation of matrix
synthesis, remodeling and accumulation in
glomerulosclerosis. Curr Pharm Des 2009;5:1318e33.
[6] Thrailkill KM, Clay Bunn R, Fowlkes JL. Matrix
metalloproteinases: their potential role in the pathogenesis
of diabetic nephropathy. Endocrine 2009;35:1e10.
[7] Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR. Targeting
of RhoA/ROCK signaling ameliorates progression of diabetic
nephropathy independent of glucose control. Diabetes
2008;57:714e23.
[8] Peng F, Wu D, Gao B, Ingram AJ, Zhang B, Chorneyko K,
McKenzie R, Krepinsky JC. RhoA/Rho-kinase contribute to
the pathogenesis of diabetic renal disease. Diabetes
2008;57:1683e92.
[9] Hirose A, Tanikawa T, Mori H, Okada Y, Tanaka Y. Advanced
glycation end products increase endothelial permeability
through the RAGE/Rho signaling pathway. FEBS Lett
2010;584:61e6.
[10] Zhang Y, Peng F, Gao B, Ingram AJ, Krepinsky JC. Mechanical
strain-induced RhoA activation requires NADPH oxidase-
mediated ROS generation in caveolae. Antioxid Redox Signal
2010;13:959e73.
[11] Dockrell ME, Phanish MK, Hendry BM. Tgf-beta auto-
induction and connective tissue growth factor expression in
human renal tubule epithelial cells requires N-ras. Nephron
Exp Nephrol 2009;112:e71e9.
[12] Grande MT, Fuentes-Calvo I, Arevalo M, Heredia F, Santos E,
Martinez-Salgado C, Rodriguez-Puyol D, Nieto MA, Lopez-
Novoa JM. Deletion of H-Ras decreases renal fibrosis and
myofibroblast activation following ureteral obstruction in
mice. Kidney Int 2010;77:509e18.
[13] Martinez-Salgado C, Fuentes-Calvo I, Garcia-Cenador B,
Santos E, Lopez-Novoa JM. Involvement of H- and N-Ras
isoforms in transforming growth factor-beta1-induced
proliferation and in collagen and fibronectin synthesis. Exp
Cell Res 2006;312:2093e106.
[14] Rodriguez-Pena AB, Grande MT, Eleno N, Arevalo M,
Guerrero C, Santos E, Lopez-Novoa JM. Activation of Erk1/2
and Akt following unilateral ureteral obstruction. Kidney Int
2008;74:196e209.
[15] Danesh FR, Sadeghi MM, Amro N, Philips C, Zeng L, Lin S,
Sahai A, Kanwar YS. 3-Hydroxy-3-methylglutaryl CoA
reductase inhibitors prevent high glucose-induced
proliferation of mesangial cells via modulation of Rho
GTPase/ p21 signaling pathway: implications for diabetic
nephropathy. Proc Natl Acad Sci U S A 2002;99:8301e5.
[16] Tavafi M. Diabetic nephropathy and antioxidants. J
Nephropathol 2013;2:20e7.
[17] Tanaka S, Yoshimura Y, Kawasaki R, Kamada C, Tanaka S,
Horikawa C, Ohashi Y, Araki A, Ito H, Akanuma Y,
Yamada N, Yamashita H, Sone H, Japan Diabetes
Complications Study Group. Fruit intake and incident
diabetic retinopathy with type 2 diabetes. Epidemiology
2013;24:204e11.
[18] Mirmiran P, Bahadoran Z, Azizi F. Functional foods-based
diet as a novel dietary approach for management of type 2
diabetes and its complications: a review. World J Diabetes
2014;5:267e81.
[19] Dugo P, Mondello L, Errante G, Zappia G, Dugo G.
Identification of anthocyanins in berries by narrow-bore
high-performance liquid chromatography with
electrospray ionization detection. J Agric Food Chem
2001;49:3987e92.
[20] Boari Lima Ade J, Duarte Correa A, Carvalho Alves AP, Patto
Abreu CM, Dantas-Barros AM. Chemical characterization of
the jabuticaba fruits (Myrciaria cauliflora Berg) and their
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 1 3 6e1 4 6146fractions. Arch Latinoam Nutr 2008;58:416e21 [Article in
Spanish].
[21] Leite-Legatti AV, Batista A^G, Dragano NRV, Marques AC,
Malta LG, Riccio MF, Eberlin MN, Machado ART, de Carvalho-
Silva LB, Ruiz ALTG, de Carvalho JE, Pastore GM, Ju´nior MRM.
Jaboticaba peel: antioxidant compounds, antiproliferative
and antimutagenic activities. Food Res Int 2012;49:596e603.
[22] Reynertson KA, Wallace AM, Adachi S, Gil RR, Yang H,
Basile MJ, D'Armiento J, Weinstein IB, Kennelly EJ. Bioactive
depsides and anthocyanins from jaboticaba (Myrciaria
cauliflora). J Nat Prod 2006;69:1228e30.
[23] Dragano NR, Marques A, Cintra DE, Solon C, Morari J, Leite-
Legatti AV, Velloso LA, Marostica-Junior MR. Freeze-dried
jaboticaba peel powder improves insulin sensitivity in high-
fat-fed mice. Br J Nutr 2013;110:447e55.
[24] Cui W, Li B, Bai Y, Miao X, Chen Q, Sun W, Tan Y, Luo P,
Zhang C, Zheng S, Epstein PN, Miao L, Cai L. Potential role for
Nrf2 activation in the therapeutic effect of MG132 on diabetic
nephropathy in OVE26 diabetic mice. Am J Physiol
Endocrinol Metab 2013;304:E87e99.
[25] Shang G, Gao P, Zhao Z, Chen Q, Jiang T, Zhang N, Li H. 3,5-
Diiodo-l-thyronine ameliorates diabetic nephropathy in
streptozotocin-induced diabetic rats. Biochim Biophys Acta
2013;1832:674e84.
[26] Komers R. Rho kinase inhibition in diabetic kidney disease.
Br J Clin Pharmacol 2013;76:551e9.
[27] Junod A, Lambert AE, Stauffacher W, Renold AE.
Diabetogenic action of streptozotocin: relationship of dose to
metabolic response. J Clin Invest 1969;48:2129e39.
[28] Nakamura T, Terajima T, Ogata T, Ueno K, Hashimoto N,
Ono K, Yano S. Establishment and pathophysiological
characterization of type 2 diabetic mouse model produced by
streptozotocin and nicotinamide. Biol Pharm Bull
2006;29:1167e74.
[29] Schein PS, Cooney DA, Vernon ML. The use of nicotinamide
to modify the toxicity of streptozotocin diabetes without loss
of antitumor activity. Cancer Res 1967;27:2324e32.
[30] Schlondorff D. The glomerular mesangial cell: an expanding
role for a specialized pericyte. FASEB J 1987;1:272e81.
[31] Zhang G, Moorhead PJ, el Nahas AM. Myofibroblasts and the
progression of experimental glomerulonephritis. Exp
Nephrol 1995;3:308e18.
[32] Howe AK, Juliano RL. Distinct mechanisms mediate the
initial and sustained phases of integrin-mediated activation
of the Raf/MEK/mitogen-activated protein kinase cascade. J
Biol Chem 1998;273:27268e74.
[33] Martinez-Salgado C, Rodriguez-Pena AB, Lopez-Novoa JM.
Involvement of small Ras GTPases and their effectors in
chronic renal disease. Cell Mol Life Sci 2008;65:477e92.
[34] Mishra A, Bhatti R, Singh A, Singh Ishar MP. Ameliorative
effect of the cinnamon oil from Cinnamomum zeylanicum
upon early stage diabetic nephropathy. Planta Med
2010;76:412e7.
[35] Eid HM, Martineau LC, Saleem A, Muhammad A, Vallerand D,
Benhaddou-Andaloussi A, Nistor L, Afshar A, Arnason JT,Haddad PS. Stimulation of AMP-activated protein kinase and
enhancement of basal glucose uptake in muscle cells by
quercetin and quercetin glycosides, active principles of the
antidiabetic medicinal plant Vaccinium vitis-idaea. Mol Nutr
Food Res 2010;54:991e1003.
[36] Kawano A, Nakamura H, Hata S, Minakawa M, Miura Y,
Yagasaki K. Hypoglycemic effect of aspalathin, a rooibos tea
component from Aspalathus linearis, in type 2 diabetic model
db/db mice. Phytomedicine 2009;16:437e43.
[37] Ribaldo PD, Souza DS, Biswas SK, Block K, Lopes de Faria JM,
Lopes de Faria JB. Green tea (Camellia sinensis) attenuates
nephropathy by downregulating Nox4 NADPH oxidase in
diabetic spontaneously hypertensive rats. J Nutr
2009;139:96e100.
[38] Al-Qattan K, Thomson M, Ali M. Garlic (Allium sativum) and
ginger (Zingiber officinale) attenuate structural nephropathy
progression in streptozotocin-induced diabetic rats. e-SPEN
2008;3:e62e71.
[39] Welt K, Weiss J, Martin R, Hermsdorf T, Drews S, Fitzl G.
Ginkgo biloba extract protects rat kidney from diabetic and
hypoxic damage. Phytomedicine 2007;14:196e203.
[40] Nascimento Gomes G, Barbosa FT, Radaeli RF, Cavanal MF,
Mello Aires M, Zaladek Gil F. Effect of D-alpha-tocopherol on
tubular nephron acidification by rats with induced diabetes
mellitus. Braz J Med Biol Res 2005;38:1043e51.
[41] Kim SS, Gallaher DD, Csallany AS. Vitamin E and probucol
reduce urinary lipophilic aldehydes and renal enlargement
in streptozotocin-induced diabetic rats. Lipids
2000;35:1225e37.
[42] Li X, Xiao Y, Gao H, Li B, Xu L, Cheng M, Jiang B, Ma Y. Grape
seed proanthocyanidins ameliorate diabetic nephropathy via
modulation of levels of AGE, RAGE and CTGF. Nephron Exp
Nephrol 2009;111:e31e41.
[43] Mansouri E, Panahi M, Ghaffari MA, Ghorbani A. Effects of
grape seed proanthocyanidin extract on oxidative stress
induced by diabetes in rat kidney. Iran Biomed J
2011;15:100e6.
[44] Li J, Lim SS, Lee JY, Kim JK, Kang SW, Kim JL, Kang YH. Purple
corn anthocyanins dampened high-glucose-induced
mesangial fibrosis and inflammation: possible
renoprotective role in diabetic nephropathy. J Nutr Biochem
2012;23:320e31.
[45] Wu SB, Dastmalchi K, Long C, Kennelly EJ. Metabolite
profiling of jaboticaba (Myrciaria cauliflora) and other
dark-colored fruit juices. J Agric Food Chem
2012;60:7513e25.
[46] Aqil F, Gupta A, Munagala R, Jeyabalan J, Kausar H,
Sharma RJ, Singh IP, Gupta RC. Antioxidant and
antiproliferative activities of anthocyanin/ellagitannin-
enriched extracts from Syzygium cumini L. (Jamun, the Indian
Blackberry). Nutr Cancer 2012;64:428e38.
[47] Weng CJ, Yen GC. Flavonoids, a ubiquitous dietary phenolic
subclass, exert extensive in vitro anti-invasive and in vivo
anti-metastatic activities. Cancer Metastasis Rev
2012;31:323e51.
